According to Globocan 2020, lung cancer is the second most common cancer in Europe, with an estimated 477,534 newly diagnosed patients. Furthermore, the advantages of digital PCR over traditional PCR technologies such as real-time polymerase chain reaction (RT PCR) and quantitative polymerase chain reaction (qPCR) are expected to drive their reliance on digital PCR market analysis periods. Furthermore, surge in healthcare expenditure of peoples in developing countries and surge in demand for accurate molecular diagnosis of disease drive the digital PCR market growth.
Digital PCR is the end-point PCR method, used for perfect authentication and to analyze minority sequences on the background of equal majority sequences. Digital PCR (DPCR) enables accurate, highly sensitive authentication of nucleic acids. Conventional PCR is an end-point analysis that is semi-quantitative because the amplified product is detected by agrose gel electrophoresis. Real-time PCR (or QPCR) uses fluorescence-based detection to allow the measurement of the incremental product accumulated as the reaction progresses.
Explore More Insights@ https://www.alliedmarketresearch.com/request-sample/654
The growth of the global digital polymerase chain reaction market is mainly due to the growth of various types of cancers such as lung cancer, leukemia and brain tumors. Digital PCR testing is used for molecular diagnosis of cancer. The growth in the research and development initiatives for the advancement of PCR technology and the increase in cooperation agreements between companies for the development of digital PCR have led to the growth of the digital PCR industry.
According to a new report published by Allied Market Research, titled, “Digital PCR Market,” The digital PCR market size was valued at $508.82 million in 2020, and is estimated to reach $1.3 Billion by 2030, growing at a CAGR of 8.6% from 2021 to 2030. The advantages of digital PCR over traditional PCR technologies such as Real Time Polymerase Chain Reaction (RT PCR) and Quantitative Polymerase Chain Reaction (qPCR) are expected to drive their reliance on the digital PCR market analysis period. Advances in digital PCR technology and an increase in the number of products in the global market are expected to contribute to the growth of the digital PCR industry. For example, in June 2021, Bio-Rad Laboratories, Inc., one of the world leaders in the field of life sciences, announced the launch of the Prevalence ddPCR SARS-CoV-2 Sewage Certification Kit for COVID-19 Sewage Testing.
The digital PCR market size is segmented on the basis of technology, product type, application, end user, and region. By technology, the market is categorized into droplet digital PCR (ddPCR), chip based digital PCR, and BEAMing digital PCR. Depending on product type, it is fragmented into digital PCR systems, consumables & reagents, and software & services. On the basis of application, it is segregated into research, clinical diagnostics, and forensic & others.
Speak With Analyst@ https://www.alliedmarketresearch.com/connect-to-analyst/654
Key Advantages:
• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the digital pcr market size analysis from 2020 to 2030 to identify the prevailing digital PCR market opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the digital pcr market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global digital pcr market trends, key players, market segments, application areas, and market growth strategies.
Customization Request@ https://www.alliedmarketresearch.com/request-for-customization/654
Key Market Players
• Avance Biosciences
• Bio-Rad Laboratories, Inc.
• Fluidigm Corporation
• jn medsys
• Merck KGAA
• Precigenome LLC
• QIAGEN N.V
• STILLA TECHNOLOGIES
• sysmex corporation
• Thermo Fisher Scientific, Inc.
Related Report:
Ophthalmic OR Microscopes Market
Cannabis Testing Market
We also Offers Regional and Country Reports:
• North America Digital PCR Market
• Japan Digital PCR Market
• South Korea Digital PCR Market
• Singapore Digital PCR Market
• Australia Digital PCR Market
• Europe Digital PCR Market
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com